BEAM:BMV
Beam Therapeutics Inc
MX$ 439.00
arrow_downward
-0.63%(-2.79) 1D
10-р сарын 2, 14:00:00 (GMT-6) · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
MX$ 439.00
High
MX$ 439.00
Low
MX$ 439.00
Mkt. cap
2.53 тэрбум
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$ 663.44
52-wk low
MX$ 384.79
No. of employees
540
Open
MX$ 439.00
High
MX$ 439.00
Low
MX$ 439.00
Mkt. cap
2.53 тэрбум
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$ 663.44
52-wk low
MX$ 384.79
No. of employees
540
News stories
From web sources and news partners
Foreign Policy Journal
·
24 минутын өмнө
Supreme Court Cases Involving Apple (NASDAQ: AAPL), Exxon (NYSE: XOM), And Intel (NASDAQ: INTC) Could Reshape Investor Portfolios
Proactive financial news
·
1 цагийн өмнө
Nova Minerals to host investor webinar on Estelle and US antimony strategy
Yahoo! Finance Canada
·
9 минутын өмнө
CABA,HERZ,TRIN,RPC,FFIN,NXRT,GO,BLCO,CULP,VSNT,KWY,FRST,VIRC,ENTX,BLIN,GRNT,SSP,GAIA,NRGV,AFCG,APCX,THRY,KLTR,BETR | Stock Prices | Quote Comparison
USA Today
·
15 цагийн өмнө
Is a stock market correction coming? Most Americans think so
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc